K811721

Substantially Equivalent

H-101 KAPPA,H-102 LAMBDA,H-107 LYSOZME

Applicant: Immulok, Inc.
Product code: DFH
Advisory panel: Immunology
Date received: 1981-06-18
Decision date: 1981-07-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.